Get started
Author

Julian Maurer

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses
2023 · Alessa Fischer, Simon Kloos, et al. · The Journal of Clinical Endocrinology & Metabolism · 50
PDF
Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro
2019 · Xi-Feng Jin, Christoph J. Auernhammer, et al. · Journal of Nuclear Medicine · 50
PDF
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures
2019 · Maria Fankhauser, Nicole Bechmann, et al. · Endocrinology · 42
PDF
Anticancer effects of metformin on neuroendocrine tumor cells in vitro
2014 · George Vlotides, Ayse Tanyeri, et al. · HORMONES · 42
PDF
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
2020 · Xi-Feng Jin, Gerald Spöttl, et al. · Cancers · 41
PDF
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
2022 · Katharina Wang, Ina Schütze, et al. · Endocrine Related Cancer · 32
PDF
Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
2013 · KATHRIN ZITZMANN, GALINA AILER, et al. · International Journal of Oncology · 31
PDF
Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways
2015 · Svenja Nölting, Julian Maurer, et al. · PLoS ONE · 27
PDF
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance
2018 · Elke Tatjana Aristizabal Prada, Gerald Spöttl, et al. · Endocrine Related Cancer · 26
PDF
The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1
2016 · Clemens Reuther, Vera Heinzle, et al. · Neuroendocrinology · 25
PDF
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro
2017 · Elke Tatjana Aristizabal Prada, Svenja Nölting, et al. · Neuroendocrinology · 23
PDF
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study
2023 · Alessa Fischer, Simon Kloos, et al. · European Journal of Endocrinology · 21
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for ‘Off-Target' Effects Not Mediated by c-Met Inhibition
2015 · Clemens Reuther, Vera Heinzle, et al. · Neuroendocrinology · 20
PDF
Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
2019 · Claudia Siebert, Denis Ciato, et al. · Frontiers in Endocrinology · 19
PDF
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors
2017 · Elke Tatjana Aristizabal Prada, Carla Weis, et al. · Neuroendocrinology · 16
PDF
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells
2017 · Elke Tatjana Aristizabal Prada, Michael Orth, et al. · PLoS ONE · 15
PDF
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures
2024 · Katharina Wang, Laura Schober, et al. · The Journal of Clinical Endocrinology & Metabolism · 10
PDF
Upregulation of SSTR2 Expression and Radioligand Binding of [18F]SiTATE in Neuroendocrine Tumour Cells with Combined Inhibition of Class I HDACs and LSD1
2025 · Christoph J. Auernhammer, Kathrin Zitzmann, et al. · Neuroendocrinology · 8
PDF
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro
2021 · Xi-Feng Jin, Gerald Spöttl, et al. · Cancers · 7
PDF
Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors
2018 · Elke Tatjana Aristizabal Prada, Vera Heinzle, et al. · Endocrine Related Cancer · 7
PDF
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors
2025 · Katharina Wang, Alessa Fischer, et al. · European Journal of Endocrinology · 5
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
2023 · Ajay-Mohan Mohan, Sonal Prasad, et al. · Endocrine Related Cancer · 4
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
2025 · Katharina Wang, Christoph J Auernhammer, et al. · Endocrine Oncology · 2
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms
2026 · Christoph J Auernhammer, Katharina Wang, et al. · The Journal of Clinical Endocrinology & Metabolism · 1
A genetic signature predicts aggressive paraganglioma sensitivity to dual PI3K-CDK4/6 inhibition therapy
2025 · Bhargavi Karna, Federica Gentile, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Works count: 32
Citation count: 527
H-index: 15
I10-index: 17
Year
Topic
Type